Linked Life Data

1741687

Source:http://linkedlifedata.com/resource/pubmed/id/1741687

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1992-1-9
pubmed:abstractText
Fluosol, a first, low-concentration fluorocarbon emulsion, was recently approved for oxygenating the myocardium during percutaneous transluminal coronary angioplasty. Improvements in fluorocarbon and emulsion technology have led to the development of significantly more stable, more efficient second-generation injectable O2 carriers. This progress extends the potential of fluorocarbons in medicine to new applications both in diagnostics and in therapeutics. Future objectives will aim at adjusting and optimizing the preparation's characteristics for each specific application. The emulsifier, or surfactant, which determines the external appearance of the fluorocarbon droplets, will play a key role in the mastery of emulsion properties. Extensive research efforts are therefore being directed toward the synthesis and evaluation of new families of surfactants or co-surfactants specifically designed for emulsifying fluorocarbons.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0160-564X
pubmed:author
pubmed:issnType
Print
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
408-13
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Fluorocarbon-based oxygen carriers: new orientations.
pubmed:affiliation
Laboratoire de Chimie Moléculaire, Université de Nice-Sophia Antipolis, France.
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't